Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Amifostine and Concomitant Cisplatin, Paclitaxel and Radiotherapy in Previously Irradiated, Recurrent Head and Neck Cancer

NCT00003251 is registered in ClinicalTrials.gov with University of Illinois at Chicago as lead sponsor.

NCT NCT00003251
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003251 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Amifostine and Concomitant Cisplatin, Paclitaxel and Radiotherapy in Previously Irradiated, Recurrent Head and Neck Cancer
Lead sponsor
University of Illinois at Chicago
Phase
Phase 1/2
Overall status
Unknown status
Start date
December 31, 1997
Completion date
Not reported
Enrollment
46 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug/agent toxicity by tissue/organ, head and neck cancer, radiation toxicity